google-site-verification=VGG-4uppFMIH5Z158y2SPtfqc0DazM19-P6kYYaW9wQ Breaking News: Britain approved Merck's antiviral drug molnupiravir, making it the first pill to be endorsed for treating Covid patients. Accéder au contenu principal

Breaking News: Britain approved Merck's antiviral drug molnupiravir, making it the first pill to be endorsed for treating Covid patients.

 
View in browser | nytimes.com
The New York Times
 

BREAKING NEWS

Britain approved Merck's antiviral drug molnupiravir, making it the first pill to be endorsed for treating Covid patients.

Thursday, November 4, 2021 8:00 AM EST

The British authorities said that the antiviral pill, originally designed to fight the flu, was "safe and effective" in reducing the risk of hospitalization and death for those at increased risk of severe symptoms.

Read the latest

 
You received this email because you signed up for NYTimes.com's Breaking News Alerts. To stop receiving these emails, unsubscribe or manage your email preferences.
Subscribe to the Times Get the NYT app
The New York Times Company, 620 Eighth Avenue, New York, NY 10018
 

Commentaires

Posts les plus consultés de ce blog

This Is What Fish Oil Supplements Actually Do

Kid draws a hilarious family portrait, featuring his mother on her period

Chris Froome sends out strong message to his rivals as he storms back to win Criterium du Dauphine for the second time